User: Guest  Login
Title:

Amisulpride is an "atypical" antipsychotic associated with low weight gain.

Document type:
Clinical Trial; Journal Article; Randomized Controlled Trial; Article
Author(s):
Leucht, S; Wagenpfeil, S; Hamann, J; Kissling, W
Abstract:
RATIONALE: It is possible that amisulpride, with its unique receptor binding profile, is not associated with significant weight gain, a serious side effect of most "atypical" antipsychotic drugs. While most "atypicals" have a high affinity for both dopamine and serotonin receptors, amisulpride has only dopamine receptor action. OBJECTIVES: To analyse the weight gain associated with amisulpride. METHODS: A pooled database of prospective randomised amisulpride studies was analysed. The mean weight...     »
Journal title abbreviation:
Psychopharmacology (Berl)
Year:
2004
Journal volume:
173
Journal issue:
1-2
Pages contribution:
112-5
Language:
eng
Fulltext / DOI:
doi:10.1007/s00213-003-1721-6
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/14647963
Print-ISSN:
0033-3158
TUM Institution:
Institut für Medizinische Statistik und Epidemiologie; Klinik und Poliklinik für Psychiatrie und Psychotherapie
 BibTeX